Mecliza-SR Tablet
Marketer
Fourtiza Healthcare Private Limited
Salt Composition
Meclizine (25mg) + Folic Acid (2.5mg)
Overview Mecliza-SR Tablet
Vertigo is effectively managed using the combined medication, Mecliza-SR Tablet. This treatment alleviates symptoms such as nausea, vomiting, dizziness, and other associated discomforts. Dosage and treatment duration for Mecliza-SR Tablet should strictly adhere to your physician's instructions, varying based on individual response and condition severity. Complete the prescribed course; premature discontinuation may lead to symptom recurrence and potential condition exacerbation. Inform your doctor about all concurrent medications, as interactions are possible. While common side effects—including vomiting, dry mouth, headache, and tiredness—are typically mild and transient, persistent symptoms warrant medical attention. Due to potential drowsiness, refrain from driving or activities requiring alertness until the medicine's effects are understood. Alcohol consumption should be avoided during treatment to minimize drowsiness.
Primary Ingredients of Mecliza-SR Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Mecliza-SR Tablet
Dizziness
Major Benefits of Mecliza-SR Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Mecliza-SR Tablet whole; do not break, crush, or chew it. While you can take it with or without food, consistency is key—take it at the same time each day.
Common Side effects of Mecliza-SR Tablet:
- Vomiting
- Dryness in mouth
- Headache
- Fatigue
- Drowsiness
- Allergic reaction
How to use Mecliza-SR Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Mecliza-SR Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, however, consistency in the time of administration is recommended.
How Mecliza-SR Tablet works:
Meclizine and folic acid are the active components of Mecliza-SR extended-release tablets.
SAFETY ADVICE
AlcoholCAUTION
Patients should exercise caution when combining Mecliza-SR tablets with alcohol. A physician's consultation is recommended.
PregnancySAFE IF PRESCRIBED
The extended-release Mecliza tablet is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Meclizine extended-release tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant. However, higher dosages or extended treatment with Meclizine extended-release tablets could induce drowsiness or other effects in the infant.
DrivingUNSAFE
Extended-release Meclizine tablets can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Meclizine extended-release tablets are likely safe for individuals with impaired kidney function. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Mecliza-SR tablets in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Mecliza-SR Tablet :
NA
Facts to Know About Mecliza-SR Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Neuroscience (Central Nervous System) |
3,018 People bought this recently